Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden

NCT02501434 is registered in ClinicalTrials.gov with Robert F. James as lead sponsor.

NCT NCT02501434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02501434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden
Lead sponsor
Robert F. James
Phase
Phase 2
Overall status
Suspended
Start date
April 30, 2016
Completion date
January 1, 2024
Enrollment
88 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, heparin-induced thrombocytopenia type ii, intracranial aneurysm, neurobehavioral manifestations, vasospasm, intracranial